ImunoTera Soluções Terapêuticas
PrivateLast Round
Accelerator
May 20, 2021
Total Funding Raised
$47,000
Company Overview
ImunoTera Soluções Terapêuticas operates in Healthcare & Life Sciences and is based in São Paulo. Its latest recorded funding round was an Accelerator round in May 2021.
ImunoTera Soluções Terapêuticas is a biotechnology company that develops therapeutic vaccines and immunotherapies for the treatment of cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImunoTera Soluções Terapêuticas Comparables
Compare ImunoTera Soluções Terapêuticas with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FUTR BIO | 81% | |
| Nykode Therapeutics | 77% | |
| Celluris | 73% |
For institutional investors. Book with your work email.
ImunoTera Soluções Terapêuticas Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 20, 2021 | ||||
| Grant | Aug 26, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ImunoTera Soluções Terapêuticas Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ministério da Ciência, Tecnologia e Inovação | Grant |
| BiotechTown | Accelerator |
| Financiadora de Estudos e Projetos | Grant |
| FAPESP | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2021
$28K round led by BiotechTown
For institutional investors. Book with your work email.
ImunoTera Soluções Terapêuticas Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ImunoTera Soluções Terapêuticas's valuation, stock price, and market status.
Is ImunoTera Soluções Terapêuticas a public or private company?
ImunoTera Soluções Terapêuticas is a private company.
What is the current stock price of ImunoTera Soluções Terapêuticas?
ImunoTera Soluções Terapêuticas is a private company, so its shares have no public market price. Caplight tracks ImunoTera Soluções Terapêuticas's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ImunoTera Soluções Terapêuticas worth (valuation)?
Valuation information for ImunoTera Soluções Terapêuticas is not publicly available.
Can I buy ImunoTera Soluções Terapêuticas stock?
ImunoTera Soluções Terapêuticas shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ImunoTera Soluções Terapêuticas's last funding round?
ImunoTera Soluções Terapêuticas's most recent funding round was Accelerator on May 20, 2021.
Who are the main investors in ImunoTera Soluções Terapêuticas?
Key investors in ImunoTera Soluções Terapêuticas include BiotechTown.
Will ImunoTera Soluções Terapêuticas IPO soon?
No public IPO plans have been announced for ImunoTera Soluções Terapêuticas.
How can I track ImunoTera Soluções Terapêuticas secondary market activity?
Caplight tracks bids, offers, and trades in ImunoTera Soluções Terapêuticas's shares on secondary markets.